Canadian Venture Capital - Unlocking the Funding Challenge

Issue  JCB, Volume 20, Number 2, 2014  From the Boardroom 

Christopher H. Jones
Blake, Cassels & Graydon LLP

DOI:https://doi.org/10.5912/jcb649


Abstract:

Canada plays a significant role in the global advancement of scientific discoveries and their translation into commercial opportunities, but is viewed as not fully realizing its commercial potential. A significant problem has been a lack of sufficient venture capital to take early-stage companies to the next level. Several recent developments may signal the arrival of a more positive venture-funding environment for life sciences and health technology enterprises, including the development of the Canadian government’s C$400 million Venture Capital Action Plan; pharmaceutical companies electing to establish or investing in venture funds and providing strategic support to early-stage ventures, including through the creation of research centres; and recent successful liquidity events for venture investors.

Keywords:Canadian ,venture capital ,recent developments ,en ,

Download PDF